respiratory
Infectious diseases

Why macrolides are a must for CAP


There is now overwhelming evidence to add macrolides to beta-lactams in empiric treatment of community acquired pneumonia (CAP), an Australian respiratory physician says. Despite controversy over the use of macrolides in CAP in recent years, most trials show major reductions in mortality, especially when they are used early, according to Professor Grant Waterer (pictured), Medical ...

Already a member?

Enter your email to keep reading.


OR